{"id":319,"date":"2025-09-26T18:35:01","date_gmt":"2025-09-26T18:35:01","guid":{"rendered":"http:\/\/www.capitalskips.com\/?p=319"},"modified":"2025-09-29T12:14:51","modified_gmt":"2025-09-29T12:14:51","slug":"rising-drug-tariffs-loom-unitedhealthcare-and-cigna-plans-to-check-in-medicare-open-enrollment","status":"publish","type":"post","link":"http:\/\/www.capitalskips.com\/index.php\/2025\/09\/26\/rising-drug-tariffs-loom-unitedhealthcare-and-cigna-plans-to-check-in-medicare-open-enrollment\/","title":{"rendered":"Rising Drug Tariffs Loom: UnitedHealthcare And Cigna Plans To Check In Medicare Open Enrollment"},"content":{"rendered":"
Starting October 1, the U.S. is taking a hard stance on pharmaceutical manufacturing: Imported brand-name, patented drugs will face a 100% tariff unless the companies behind them are already building plants in America. The White House says the move is about strengthening supply chains, but there\u2019s a more immediate concern for consumers\u2014higher prescription prices could be on the horizon.<\/p>\n
That\u2019s why this fall\u2019s Medicare open enrollment window, which begins October 15, is more important than ever. With potential drug price hikes just weeks away, now\u2019s the time to look closely at your prescription coverage and make sure you\u2019re not overpaying for the medications you rely on.<\/p>\n
Drug prices were already rising before this announcement. Many seniors say they skip or ration medications due to cost, and brand-name drugs\u2014which are often imported or rely on foreign manufacturing\u2014tend to be the most expensive. Doubling tariffs could increase those prices, especially for medications without a generic alternative.<\/p>\n
That said, the prescription drug market is huge and highly complex, and the ultimate impact of these tariffs is difficult to predict. Some foreign manufacturers could be shielded by existing trade agreements, or may already have U.S. partnerships in place, which could blunt the effect on consumer prices\u2014at least in the short term.<\/p>\n
Insurance companies may respond by adjusting their formularies, raising copays or changing premiums. That makes it crucial to review your plan this fall. A little comparison shopping now could save you hundreds of dollars next year.<\/p>\n
Before choosing a plan, it\u2019s smart to look at multiple carriers side by side. Comparison tools let you plug in your medications and see how much each plan would cost you over a year\u2014factoring in premiums, deductibles, copays and pharmacy options.<\/p>\n
The advantage here is personalization. Instead of picking a plan based on general benefits, you\u2019ll see how each option performs based on your prescriptions. You can also compare plan ratings, drug coverage tiers, and which pharmacies offer the best pricing. In a year when drug costs could swing sharply, that kind of transparency can make a real difference.<\/p>\n